Cargando…
AMPK inhibitor, compound C, inhibits coronavirus replication in vitro
The coronavirus disease (COVID-19) pandemic has resulted in more than six million deaths by October 2022. Vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 are now available; however, more effective antiviral drugs are required for effective treatment. Here, we report that...
Autores principales: | Jang, Minsu, Park, Rackhyun, Yamamoto, Ayane, Park, Yea-In, Park, Yeonjeong, Lee, Siyun, Park, Junsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547180/ https://www.ncbi.nlm.nih.gov/pubmed/37788269 http://dx.doi.org/10.1371/journal.pone.0292309 |
Ejemplares similares
-
Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants
por: Park, Junsoo, et al.
Publicado: (2022) -
EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro
por: Jang, Minsu, et al.
Publicado: (2021) -
Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model
por: Park, Rackhyun, et al.
Publicado: (2021) -
6-Azauridine Induces Autophagy-Mediated Cell Death via a p53- and AMPK-Dependent Pathway
por: Cha, Yeo-Eun, et al.
Publicado: (2021) -
Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases
por: Park, Junsoo, et al.
Publicado: (2021)